TY  - JOUR
A1  - Steinbrunn, Torsten
A1  - Chatterjee, Manik
A1  - Bargou, Ralf C.
A1  - Stühmer, Thorsten
T1  - Efficient Transient Transfection of Human Multiple Myeloma Cells by Electroporation - An Appraisal
JF  - PLoS ONE
N2  - Cell lines represent the everyday workhorses for in vitro research on multiple myeloma (MM) and are regularly employed in all aspects of molecular and pharmacological investigations. Although loss-of-function studies using RNA interference in MM cell lines depend on successful knockdown, no well-established and widely applied protocol for efficient transient transfection has so far emerged. Here, we provide an appraisal of electroporation as a means to introduce either short-hairpin RNA expression vectors or synthesised siRNAs into MM cells. We found that electroporation using siRNAs was much more efficient than previously anticipated on the basis of transfection efficiencies deduced from EGFP-expression off protein expression vectors. Such knowledge can even confidently be exploited in "hard-to-transfect" MM cell lines to generate large numbers of transient knockdown phenotype MM cells. In addition, special attention was given to developing a protocol that provides easy implementation, good reproducibility and manageable experimental costs.
KW  - cell cultures
KW  - green fluorescent protein
KW  - oligonucleotides
KW  - multiple myeloma
KW  - plasmid construction
KW  - transfection
KW  - small interfering RNAs
KW  - electroporation
Y1  - 2014
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-119616
VL  - 9
IS  - 6
ER  - 
TY  - JOUR
A1  - Brünnert, Daniela
A1  - Seupel, Raina
A1  - Goyal, Pankaj
A1  - Bach, Matthias
A1  - Schraud, Heike
A1  - Kirner, Stefanie
A1  - Köster, Eva
A1  - Feineis, Doris
A1  - Bargou, Ralf C.
A1  - Schlosser, Andreas
A1  - Bringmann, Gerhard
A1  - Chatterjee, Manik
T1  - Ancistrocladinium A induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate
JF  - Pharmaceuticals
N2  - The N,C-coupled naphthylisoquinoline alkaloid ancistrocladinium A belongs to a novel class of natural products with potent antiprotozoal activity. Its effects on tumor cells, however, have not yet been explored. We demonstrate the antitumor activity of ancistrocladinium A in multiple myeloma (MM), a yet incurable blood cancer that represents a model disease for adaptation to proteotoxic stress. Viability assays showed a potent apoptosis-inducing effect of ancistrocladinium A in MM cell lines, including those with proteasome inhibitor (PI) resistance, and in primary MM cells, but not in non-malignant blood cells. Concomitant treatment with the PI carfilzomib or the histone deacetylase inhibitor panobinostat strongly enhanced the ancistrocladinium A-induced apoptosis. Mass spectrometry with biotinylated ancistrocladinium A revealed significant enrichment of RNA-splicing-associated proteins. Affected RNA-splicing-associated pathways included genes involved in proteotoxic stress response, such as PSMB5-associated genes and the heat shock proteins HSP90 and HSP70. Furthermore, we found strong induction of ATF4 and the ATM/H2AX pathway, both of which are critically involved in the integrated cellular response following proteotoxic and oxidative stress. Taken together, our data indicate that ancistrocladinium A targets cellular stress regulation in MM and improves the therapeutic response to PIs or overcomes PI resistance, and thus may represent a promising potential therapeutic agent.
KW  - multiple myeloma
KW  - ancistrocladinium A
KW  - naphthylisoquinoline alkaloids
KW  - proteasome inhibitor resistance
KW  - RNA splicing
KW  - cellular stress response
KW  - proteasome subunit beta type-5 (PSMB5)
KW  - activating transcription factor 4 (ATF4)
KW  - ataxia teleagiectasia mutated (ATM)
KW  - H2A histone family member X (H2AX)
Y1  - 2023
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-362887
SN  - 1424-8247
VL  - 16
IS  - 8
ER  -